On Monday, Shares of Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP), skyrocketed 81.19% to $18.88, hitting its highest level.
Aquinox Pharmaceuticals declared results from secondary endpoints from its Phase 2 LEADERSHIP trial with AQX-1125 in patients with bladder pain syndrome/interstitial cystitis (BPS/IC). Aquinox also offered a general business update and stated financial results for the second quarter ending June 30, 2015.
Aquinox Pharmaceuticals Inc., a clinical-stage pharmaceutical company, engages in discovering and developing targeted therapeutics for diseases in the areas of inflammation and immuno-oncology.
Shares of Gerdau S.A. (NYSE:GGB), inclined 3.51% to $1.77, during its last trading session.
Goldman Sachs initiated coverage on shares of Gerdau S.A. (NYSE:GGB). Goldman Sachs issued a buy rating and a $2.30 price target on the stock.
Gerdau S.A. produces and commercializes steel products worldwide. It operates through Brazil, North America, Latin America, Special Steel, and Iron Ore segments.
Finally, Penn Virginia Corporation (NYSE:PVA), ended its last trade with 15.19% surge, and closed at $1.07.
Penn Virginia Corporation’s stock was downgraded to “neutral” from “outperform” at Credit Suisse on Friday morning.
The firm also lowered its price target on the stock to $1 from $4.
The company’s initial 2016 budget implies a cash flow deficit of about $147 million and projected liquidity of about $200 million for the end of 2015, Credit Suisse said in an analyst note.
Penn Virginia Corporation, an independent oil and gas company, explores, develops, and produces crude oil, natural gas liquids, and natural gas in various onshore regions of the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
